Year |
Citation |
Score |
2019 |
Fulcher JM, Petersen ME, Giesler RJ, Cruz ZS, Eckert DM, Francis JN, Kawamoto EM, Jacobsen MT, Kay MS. Chemical synthesis of Shiga toxin subunit B using a next-generation traceless "helping hand" solubilizing tag. Organic & Biomolecular Chemistry. PMID 31793605 DOI: 10.1039/C9Ob02012H |
0.692 |
|
2019 |
Smith AR, Weinstock MT, Siglin AE, Whitby FG, Francis JN, Hill CP, Eckert DM, Root MJ, Kay MS. Characterization of resistance to a potent D-peptide HIV entry inhibitor. Retrovirology. 16: 28. PMID 31640718 DOI: 10.1186/S12977-019-0489-7 |
0.777 |
|
2018 |
Redman JS, Francis JN, Marquardt R, Papac D, Mueller AL, Eckert DM, Welch BD, Kay MS. Pharmacokinetic and chemical synthesis optimization of a potent D-peptide HIV entry inhibitor suitable for extended-release delivery. Molecular Pharmaceutics. PMID 29436835 DOI: 10.1021/Acs.Molpharmaceut.7B01004 |
0.722 |
|
2015 |
Francis JN, Thaburet JF, Bonnet D, Sizer PJ, Brown CB, Georges B. Increasing cellular immunogenicity to peptide-based vaccine candidates using a fluorocarbon antigen delivery system. Vaccine. 33: 1071-6. PMID 25573036 DOI: 10.1016/j.vaccine.2014.12.061 |
0.473 |
|
2012 |
Weinstock MT, Francis JN, Redman JS, Kay MS. Protease-resistant peptide design-empowering nature's fragile warriors against HIV. Biopolymers. 98: 431-42. PMID 23203688 DOI: 10.1002/Bip.22073 |
0.723 |
|
2012 |
Francis JN, Redman JS, Eckert DM, Kay MS. Design of a modular tetrameric scaffold for the synthesis of membrane-localized D-peptide inhibitors of HIV-1 entry. Bioconjugate Chemistry. 23: 1252-8. PMID 22545664 DOI: 10.1021/Bc300076F |
0.73 |
|
2010 |
Welch BD, Francis JN, Redman JS, Paul S, Weinstock MT, Reeves JD, Lie YS, Whitby FG, Eckert DM, Hill CP, Root MJ, Kay MS. Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance. Journal of Virology. 84: 11235-44. PMID 20719956 DOI: 10.1128/Jvi.01339-10 |
0.738 |
|
2005 |
Francis JN, Larché M. Peptide-based vaccination: where do we stand? Current Opinion in Allergy and Clinical Immunology. 5: 537-43. PMID 16264335 |
0.381 |
|
2000 |
Francis JN, Lamont AG, Thompson SJ. The route of administration of an immunodominant peptide derived from heat-shock protein 65 dramatically affects disease outcome in pristane-induced arthritis Immunology. 99: 338-344. PMID 10712662 DOI: 10.1046/j.1365-2567.2000.00969.x |
0.367 |
|
Show low-probability matches. |